Cholangiocarcinoma is the second primary liver malignancy in terms of frequency. There are few data regarding the molecular pathogenesis and signaling cascades implicated in this tumor. This project aims to develop a molecular classification of the disease based on whole-genome expression and DNA copy number data. In addition, we aim at identifying novel molecular targets susceptible to selective blockade, followed by their experimental validation.
Translational research in liver cancer